Literature DB >> 24505886

Stability and change in the clinical course of schizoaffective disorder.

Anca Durla1, M Lenciu2, C Bredicean2, I Papava2, M Cristanovici.   

Abstract

UNLABELLED: Schizoaffective disorder currently raises several questions, one of them being related to the stability of the clinical diagnosis over time. The aim of this study is to identify the clinical and evolutional particularities in the longitudinal course of schizoaffective disorder.
MATERIAL AND METHODS: 44 subjects with a current diagnosis of schizoaffective disorder have been assessed prospectively. Following parameters were analyzed: socio-demographic (age at onset, gender, educational, professional and marital status at onset) and clinical (total duration of evolution, diagnosis at onset, duration of the evolution until the switch to the schizoaffective disorder diagnosis). RESULTS AND DISCUSSION: Socio-demographic parameters are similar to those in literature and the clinical assessment revealed that schizoaffective disorder is present as a diagnosis along with the longitudinal course of other types of psychosis.
CONCLUSIONS: Schizoaffective disorder appears as a heterogeneous pathology in terms of the longitudinal course.

Entities:  

Mesh:

Year:  2013        PMID: 24505886

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  2 in total

1.  Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder.

Authors:  Dusan Hirjak; Achim Hochlehnert; Philipp Arthur Thomann; Katharina Maria Kubera; Knut Schnell
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

2.  Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Margaret Heslin; Daniel Stahl; Zera Brittenden; Edgardo Caverzasi; Philip McGuire; William T Carpenter
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.